MedPath

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

Phase 3
Recruiting
Conditions
Prurigo Nodularis
Interventions
Drug: Placebo
Registration Number
NCT06527404
Lead Sponsor
Amgen
Brief Summary

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
460
Inclusion Criteria
  • Age ≥ 18 years (or any legal adult age within the country if it is older than 18 years)
  • Clinical Diagnosis of Prurigo Nodularis that has been present for at least 3 months.
  • Patient-reported average Daily Itch Score based on electronic daily diary assessment the last 7 days prior to and including day 1.
  • Has ≥ 20 prurigo nodularis nodules in total with bilateral distribution on both legs and /or arms and /or trunk.
  • History of inadequate response to topical therapies of medium or higher potency or for whom topical treatments are otherwise medically inadvisable (eg, because of important side effects or safety risks).
Exclusion Criteria
  • Skin or systemic morbidities, other than prurigo nodularis, that have been active within the last 3 months that interfere with assessment of study outcomes including but not limited to atopic dermatitis (signs or symptoms other than dry skin or requiring treatment is not allowed; use of emollients and/or history of AD is allowed).
  • Prurigo nodularis secondary to medications.
  • Prurigo nodularis secondary to neurologic or psychiatric medical conditions.
  • Treatment with any systemic biologic immunosuppressive or systemic biologic immunomodulatory therapy for prurigo nodularis or any other autoimmune, inflammatory, or allergic disease within 12 weeks or 5 half-lives, whichever is longer, prior to day 1 prerandomization.
  • Treatment with live virus including live attenuated vaccination 12 weeks prior to day 1 prerandomization.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A: Blinded TreatmentRocatinlimabParticipants will receive rocatinlimab dose 1 subcutaneously (SC) during Treatment Period A and B.
Arm C: Blinded TreatmentPlaceboParticipants will receive matching placebo SC during Treatment Period A and B.
Arm B: Blinded TreatmentRocatinlimabParticipants will receive rocatinlimab dose 2 SC during Treatment Period A and B.
Arm D: Open-labelRocatinlimabParticipants will receive open-label rocatinlimab dose 1 SC during Treatment Period B.
Primary Outcome Measures
NameTimeMethod
Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score at Week 24Up to 24 weeks
US Only: Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score and Prurigo Nodularis Assessment at Week 24Up to 24 weeks
Secondary Outcome Measures
NameTimeMethod
Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Sleep Disturbance Assessment Score at Week 24 in Participants with Baseline Weekly Average Score Greater Than a Cutoff ScoreBaseline and week 24
Change from Baseline in Quality of Life Assessment Score at Week 16Baseline and week 16
Number of Participants Achieving Improvement in Prurigo Nodularis Assessment Score at Week 24Week 24
Global: Percentage Improvement from Baseline in Weekly Average of Daily Itch Score at Week 24Baseline and Week 24
Global: Number of Participants Achieving Reduction in Weekly Average Daily Prurigo Nodularis Skin Pain Assessment at Week 24 in Those with Baseline NRS Above CutoffBaseline and Week 24
US Only: Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score at Week 24Baseline and Week 24
US Only: Number of Participants with Improvement in Prurigo Nodularis Assessment at Week 24Week 24
Number of Participants Achieving Reduction from Baseline in Weekly Average of Daily Itch Score at Week 16Baseline and Week 16
Number of Participants Achieving Improvement in Prurigo Nodularis Assessment Score at Week 16Week 16
Change from Baseline in Weekly Average of Daily Itch Score at Week 24Baseline and Week 24
Change from Baseline in Prurigo Nodularis Assessment Score at Week 24Baseline and Week 24
Number of Participants Achieving Reduction from Baseline in Quality of Life Assessment Score at Week 24 in Participants with Baseline Score Greater Than a Cutoff ScoreBaseline and Week 24
Change from Baseline in Quality of Life Assessment Score at Week 24Baseline and Week 24
Change from Baseline in Weekly Average of Daily Skin Pain Assessment Score at Week 24Baseline and Week 24
Change from Baseline in Weekly Average of Daily Sleep Disturbance Assessment Score at Week 24Baseline and Week 24
Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Up to approximately Week 68

An adverse event (AE) is any untoward medical occurrence in a clinical study subject irrespective of a causal relationship with the study treatment. TEAEs are any event that occurred after the participant received study treatment. Any clinically significant changes in vital signs, electrocardiograms, and clinical laboratory tests that occurred after study treatment administration will be recorded as TEAEs. A serious TEAE is any untoward medical occurrence that meets one of the following criteria: Is immediately life-threatening, requires in-patient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or another medically important serious event.

Number of Participants Experiencing AEs of Special Interest (EOIs)Up to approximately Week 68
Number of Participants with Anti-rocatinlimab AntibodiesBaseline to Week 68
Serum Concentrations of RocatinlimabBaseline to Week 52
Trough Concentration (Ctrough) of RocatinlimabBaseline to Week 52

Trial Locations

Locations (180)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

First OC Dermatology

🇺🇸

Fountain Valley, California, United States

Los Angeles Universal Research Center

🇺🇸

Los Angeles, California, United States

Paradigm Clinical Research Center Inc

🇺🇸

San Diego, California, United States

Wolverine Clinical Trials

🇺🇸

Tustin, California, United States

Direct Helpers Research Center

🇺🇸

Hialeah, Florida, United States

Wellness Clinical Research

🇺🇸

Miami Lakes, Florida, United States

Southern Clinical Research

🇺🇸

Miami, Florida, United States

University of Miami Hospital

🇺🇸

Miami, Florida, United States

Miami Dermatology and Laser Institute

🇺🇸

Miami, Florida, United States

Clinical Research Trials of Florida Inc

🇺🇸

Tampa, Florida, United States

Olympian Clinical Research - Tampa

🇺🇸

Tampa, Florida, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Endeavor Health Clinical Trials Center

🇺🇸

Skokie, Illinois, United States

The Indiana Clinical Trials Center PC

🇺🇸

Plainfield, Indiana, United States

Revival Research Institute, LLC

🇺🇸

Troy, Michigan, United States

Icahn School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

Optima Research

🇺🇸

Boardman, Ohio, United States

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Wright State Physicians

🇺🇸

Fairborn, Ohio, United States

Hightower Clinical

🇺🇸

Oklahoma City, Oklahoma, United States

Center For Clinical Studies PLLC

🇺🇸

Houston, Texas, United States

Clarity Dermatology

🇺🇸

Lancaster, Texas, United States

Springville Dermatology

🇺🇸

Springville, Utah, United States

Hospital Universitario Austral

🇦🇷

Derqui, Pilar, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas de Cordoba

🇦🇷

Cordoba, Córdoba, Argentina

Instituto de Neumonologia y Dermatologia

🇦🇷

Ciudad Autonoma de Buenos Aires, Distrito Federal, Argentina

Derma Internacional

🇦🇷

Ciudad Autonoma de Buenos Aires, Distrito Federal, Argentina

Centro de investigacion clinica y epidemiologica

🇦🇷

San Miguel D Tucuman, Tucuman, Argentina

Parra Dermatologia

🇦🇷

Mendoza, Argentina

St George Dermatology and Skin Cancer Centre

🇦🇺

Kogarah, New South Wales, Australia

Veracity Clinical Research

🇦🇺

Woolloongabba, Queensland, Australia

Box Hill Hospital

🇦🇺

Box Hill, Victoria, Australia

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

The Royal Melbourne Hospital

🇦🇺

Parkville, Victoria, Australia

Medizinische Universitaet Graz

🇦🇹

Graz, Austria

Ordensklinikum Linz Elisabethinen

🇦🇹

Linz, Austria

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

🇧🇪

Bruxelles, Belgium

Universitaire Ziekenhuizen Leuven Gasthuisberg

🇧🇪

Leuven, Belgium

Centre Hospitalier Universitaire de Liege - Sart Tilman

🇧🇪

Liege, Belgium

Clinica Instituto Bahiano de Imunoterapia - Medicina, Reumatologia e Dermatologia ltda

🇧🇷

Salvador, Bahia, Brazil

Doctor Chih-Ho Hong Medical Incorporated

🇨🇦

Surrey, British Columbia, Canada

CCA Medical Research Corp

🇨🇦

Ajax, Ontario, Canada

Centricity Research London Victoria

🇨🇦

London, Ontario, Canada

Lovegrove Dermatology

🇨🇦

London, Ontario, Canada

Lynderm Research Inc

🇨🇦

Markham, Ontario, Canada

SKiN Centre for Dermatology

🇨🇦

Peterborough, Ontario, Canada

York Dermatology Clinic and Research Centre

🇨🇦

Richmond Hill, Ontario, Canada

Toronto Research Centre Inc

🇨🇦

Toronto, Ontario, Canada

AvantDerm

🇨🇦

Toronto, Ontario, Canada

Alliance Clinical Trials

🇨🇦

Waterloo, Ontario, Canada

Centre de Recherche Dermatologique du Quebec Metropolitain

🇨🇦

Quebec, Canada

Enroll SpA

🇨🇱

Providencia, Santiago, Chile

Centro Medico Skinmed Spa

🇨🇱

Santiago, Chile

Fundacion Innovacion Cardiovascular Clinica Ensenada

🇨🇱

Santiago, Chile

Centro Internacional de Estudios Clinicos

🇨🇱

Santiago, Chile

Clinical Research Chile SpA

🇨🇱

Valdivia, Chile

Peking University First Hospital

🇨🇳

Beijing, Beijing, China

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

The First Affiliated Hospital Sun-Yat Sen University

🇨🇳

Guangzhou, Guangdong, China

Dermatology Hospital of Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University

🇨🇳

Nanning, Guangxi, China

Sanmenxia Central Hospital

🇨🇳

Sanmenxia, Henan, China

The Second Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

Wuxi Peoples Hospital

🇨🇳

Wuxi, Jiangsu, China

Dermatology Hospital of Jiangxi Province

🇨🇳

Nanchang, Jiangxi, China

The First Bethune Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

The Second Affiliated Hospital Of Xi An Jiaotong University

🇨🇳

XI An, Shaanxi, China

Huashan Hospital Affiliated to Fudan University

🇨🇳

Shanghai, Shanghai, China

Shanghai Skin Disease Hospital

🇨🇳

Shanghai, Shanghai, China

Chengdu Second Peoples Hospital

🇨🇳

Chengdu, Sichuan, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, Tianjin, China

The Second Affliated Hospital of Kunming Medical University

🇨🇳

Kunming, Yunnan, China

Affiliated Hangzhou First Peoples Hospital School of Medicine Westlake University

🇨🇳

Hangzhou, Zhejiang, China

Clinical Research Services Helsinki

🇫🇮

Helsinki, Finland

Oulun Yliopistollinen sairaala

🇫🇮

Oulu, Finland

Terveystalo Tampere

🇫🇮

Tampere, Finland

Centre Hospitalier Regional Universitaire de Brest - Hopital Morvan

🇫🇷

Brest, France

Centre Hospitalier Le Mans

🇫🇷

Le Mans Cedex 9, France

Cabinet du Docteur Ruer-Mulard Mireille

🇫🇷

Martigues, France

Centre Hospitalier Universitaire Archet 2

🇫🇷

Nice, France

Centre Hospitalier Universitaire de Rouen - Hopital Charles Nicolle

🇫🇷

Rouen Cedex, France

Universitaetsklinikum Augsburg

🇩🇪

Augsburg, Germany

Fachklinik Bad Bentheim

🇩🇪

Bad Bentheim, Germany

Charite - Universitaetsmedizin Berlin, Campus Virchow

🇩🇪

Berlin, Germany

Rosenpark Research GmbH

🇩🇪

Darmstadt, Germany

Universitaetsklinikum Dresden

🇩🇪

Dresden, Germany

Universitaetsklinikum Schleswig-Holstein

🇩🇪

Kiel, Germany

Universitaetsmedizin Mainz

🇩🇪

Mainz, Germany

Universitaetsklinikum Muenster

🇩🇪

Muenster, Germany

Hautarztpraxis Mortazawi

🇩🇪

Remscheid, Germany

Universitaetsklinikum Tuebingen

🇩🇪

Tuebingen, Germany

Helios Klinikum Wuppertal

🇩🇪

Wuppertal, Germany

University General Hospital Attikon

🇬🇷

Athens, Greece

Andreas Syngros Hospital Of Venereal And Dermatological Diseases

🇬🇷

Athens, Greece

General Hospital Of Nea Ionia Konstantopouleio Patision

🇬🇷

Nea Ionia, Greece

Ippokratio General Hospital of Thessaloniki

🇬🇷

Thessaloniki, Greece

Papageorgiou General Hospital

🇬🇷

Thessaloniki, Greece

Queen Mary Hospital, The University of Hong Kong

🇭🇰

Hong Kong, Hong Kong

Obudai Egeszsegugyi Centrum Kft

🇭🇺

Budapest, Hungary

Debreceni Egyetem Klinikai Kozpont

🇭🇺

Debrecen, Hungary

Derm-Surg Kft

🇭🇺

Kaposvar, Hungary

DermaMed Research Kft

🇭🇺

Oroshaza, Hungary

Pecsi Tudomanyegyetem Klinikai Kozpont

🇭🇺

Pecs, Hungary

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar

🇭🇺

Szeged, Hungary

Ospedale San Salvatore

🇮🇹

LAquila, Italy

Azienda Ospedaliera Luigi Sacco

🇮🇹

Milano, Italy

Azienda Ospedaliero Universitaria di Modena

🇮🇹

Modena, Italy

Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia

🇮🇹

Perugia, Italy

Fondazione Policlinico Tor Vergata

🇮🇹

Roma, Italy

Fujita Health University Hospital

🇯🇵

Toyoake-shi, Aichi, Japan

Ogaki Municipal Hospital

🇯🇵

Ogaki-shi, Gifu, Japan

Medical Corporation Kojinkai Sapporo Skin Clinic

🇯🇵

Sapporo-shi, Hokkaido, Japan

Mito Kyodo General Hospital

🇯🇵

Mito-shi, Ibaraki, Japan

Kochi Medical School Hospital

🇯🇵

Nankoku-shi, Kochi, Japan

Noguchi Dermatology Clinic

🇯🇵

Kamimashiki-gun, Kumamoto, Japan

Nagasaki University Hospital

🇯🇵

Nagasaki-shi, Nagasaki, Japan

Hayami Dermatology Clinic

🇯🇵

Osaka-shi, Osaka, Japan

Dokkyo Medical University Saitama Medical Center

🇯🇵

Koshigaya-shi, Saitama, Japan

National Defense Medical College hospital

🇯🇵

Tokorozawa-shi, Saitama, Japan

Institute of Science Tokyo Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

Tokyo Teishin Hospital

🇯🇵

Chiyoda-ku, Tokyo, Japan

Shirasaki Dermatology Clinic

🇯🇵

Takaoka-shi, Toyama, Japan

Tokyo Medical University Hospital

🇯🇵

Shinjyuku-ku, Japan

Korea University Ansan Hospital

🇰🇷

Ansansi, Gyeonggido, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

Hanyang University Seoul Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Hallym University Kangnam Sacred Heart Hospital

🇰🇷

Seoul, Korea, Republic of

J Kisis

🇱🇻

Riga, Latvia

Outpatient clinic Veselibas Centrs 4

🇱🇻

Riga, Latvia

Outpatient clinic Veselibascentrs 4

🇱🇻

Riga, Latvia

Universitair Medisch Centrum Utrecht

🇳🇱

Utrecht, Netherlands

Niepubliczny Zaklad Opieki Zdrowotnej

🇵🇱

Bialystok, Poland

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdansk, Poland

AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy

🇵🇱

Gdansk, Poland

GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero

🇵🇱

Katowice, Poland

Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne

🇵🇱

Lodz, Poland

Dermedic Jacek Zdybski

🇵🇱

Ostrowiec Swietokrzyski, Poland

Uniwersytecki Szpital Kliniczny imienia Fryderyka Chopina w Rzeszowie

🇵🇱

Rzeszow, Poland

Centrum Zdrowia Dziecka i Rodziny Im Jana Pawla II w Sosnowcu Osrodek Badan Klinicznych

🇵🇱

Sosnowiec, Poland

Royalderm Agnieszka Nawrocka

🇵🇱

Warszawa, Poland

Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spolka Partnerska

🇵🇱

Wroclaw, Poland

DermMedica Spzoo Centrum Columbus

🇵🇱

Wroclaw, Poland

Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria

🇵🇹

Lisboa, Portugal

Hospital Cuf Descobertas

🇵🇹

Lisboa, Portugal

Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio

🇵🇹

Porto, Portugal

Spitalul Clinic Judetean de Urgenta Cluj-Napoca

🇷🇴

Cluj-Napoca, Romania

Spitalul Clinic Judetean Mures

🇷🇴

Targu Mures, Romania

Hospital Universitario Reina Sofia

🇪🇸

Cordoba, Andalucía, Spain

Hospital Universitario Miguel Servet

🇪🇸

Zaragoza, Aragón, Spain

Hospital Universitario de Gran Canaria Doctor Negrin

🇪🇸

Las Palmas de Gran Canaria, Canarias, Spain

Hospital Universitari Germans Trias i Pujol

🇪🇸

Badalona, Cataluña, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Cataluña, Spain

Hospital General Universitario de Alicante

🇪🇸

Alicante, Comunidad Valenciana, Spain

Hospital Universitario de La Princesa

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Diagnostiskt Centrum Hud i Sickla

🇸🇪

Nacka, Sweden

Akademiska sjukhuset

🇸🇪

Uppsala, Sweden

Inselspital Bern

🇨🇭

Bern, Switzerland

Universitaetsspital Zuerich

🇨🇭

Zuerich Flughafen, Switzerland

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Mackay Memorial Hospital Taipei Branch

🇨🇳

Taipei, Taiwan

Linkou Chang Gung Memorial Hospital

🇨🇳

Taoyuan, Taiwan

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

Ankara Bilkent Sehir Hastanesi

🇹🇷

Ankara, Turkey

Adnan Menderes Universitesi Medical Faculty

🇹🇷

Aydin, Turkey

Pamukkale Universitesi Tip Fakultesi Hastanesi

🇹🇷

Denizli, Turkey

Gaziantep Universitesi Tip Fakultesi Hastanesi

🇹🇷

Gaziantep, Turkey

Izmir Demokrasi Universitesi Buca Seyfi Demirsoy Egitim ve Arastirma Hastanesi

🇹🇷

Izmir, Turkey

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

🇹🇷

Samsun, Turkey

Chapel Allerton Hospital

🇬🇧

Leeds, United Kingdom

Royal London Hospital

🇬🇧

London, United Kingdom

Guys Hospital

🇬🇧

London, United Kingdom

Ameli-Biogroup Limited

🇬🇧

Waltham Abbey, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath